Drugs / SPARC1023
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01304303 | Oct 2011 → Oct 2016 | high grade malignant neoplasm | Sun Pharma Advanced Research Company Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPARC1023 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01304303 ↗ |
| Route | Intravenous | “IV administration” NCT01304303 ↗ |